System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Dafna D Gladman is an expert in Rheumatology at Toronto Western Hospital (Canada). As of October 2026, ScienceLeadR ranks Dafna D Gladman in the top 1% of experts worldwide for Spondylarthritis, Arthritis and Psoriasis. Dafna D Gladman has authored 1,525 publications, the most recent in 2026, and is an investigator in 27 clinical trials, 1 of them ongoing. SLR score: 5,072 (community average: 125). How the SLR is computed.

LeadR Profile

Dafna D Gladman Toronto Western Hospital Canada
5 072 ScienceLeadR Reputation 5072

Unlock

Register Login
Network Map

Rheumatology

Subspecialties: Dermatology - Internal Medicine - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1987 - 2026
Source: PubMed

Mount Sinai Hospital (Canada)

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1525

Citations

Citations: 104 891 1st author: 175 Last author: 333 Unique author: 79

Main journals

J Rheumatol 377
Ann Rheum Dis 278
Arthritis Rheum 85
Rheumatology (Oxford) 80
Arthritis Care Res (Hoboken) 65

Best Journals

Nat Rev Rheumatol 5
N Engl J Med 4
Lancet Rheumatol 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Cost-effectiveness of early versus delayed disease-modifying antirheumatic drugs for psoriatic arthritis.
PMID 42921371 — arthritis, psoriatic, pharmaceutical preparations, antirheumatic agents, arthritis, quality-adjusted life years, therapeutics		Lancet Reg Health Am20260
Antimalarial exposure and renal histopathologic findings in LN.
PMID 42853650 — fibrosis, lupus nephritis, kidney, biopsy, rheumatic diseases, therapeutics, antimalarials, nephritis		Rheumatology (Oxford)20260
Investigating the association between interferons and flares of systemic lupus erythematosus at a single cell level.
PMID 42903145 — cells, genes, lupus erythematosus, systemic		Front Immunol20260
Associations Between Clinical Characteristics and Magnetic Resonance Imaging of the Sacroiliac Joints and Spine: Exploratory Analysis of the Phase 4, Randomized, Placebo-Controlled STAR Study.
PMID 42898665 — arthritis, psoriatic, pain, magnetic resonance imaging, demography, spine		J Psoriasis Psoriatic Arthritis20260
Repeat biopsy in membranous lupus nephritis: extending the lens beyond light microscopy.
PMID 42641199 — arthritis, lupus nephritis, biopsy, rheumatic diseases, microscopy, nephritis		Semin Arthritis Rheum20260

Clinical Studies 27

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Chair: 1

By phase:

Phase 3 18
Phase 2 4
Phase 4 3
N/A 2

By status:

Completed 23
Terminated 2
Active not recruiting 1
Unknown 1

By type:

Interventional 25
Observational 2

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 1
multicentric5to9 0
multicentricup10 23

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study of Guselkumab Administered Subcutaneously in Bio naive Participants With Active Psoriatic Arthritis Axial Disease
NCT04929210 — injections, arthritis, psoriatic, safety, arthritis, injections, subcutaneous		Phase 4Active not recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS